Alongside the CBD boom, the functional Mushroom market has experienced a profound amount of growth with certain estimates putting market growth upwards of $35 Billion. Similarly situated to cannabis treatments as both controversial and poorly understood, there remains tremendous potential on the horizon for mycelia like Cordycepin and Psilocybin. As consumers look to herbal treatments for an assortment of ailments and quality of life improves the future of hemp products and mushrooms while regulations take shape the question remains whether or not there is a future for CBD and Mushrooms.

Table of contents
00:00:30 Psychedelic drug
00:05:31 The clinical background
00:09:41 Neuroplasticity
00:13:41 The serotonin system
00:18:50 Treatments that can affect you
00:21:52 Anti-inflammatory
00:25:31 Tetrahydrocannabinol
00:29:41 Food and Drug Administration
00:33:19 Psilocybin mushroom
00:36:47 Major depressive disorder
00:41:07 Legalizing of the cannabis
00:46:05 The opposition
00:51:40 Medical cannabis

source